Abstract
The oncoproteins MDM2 and MDMX negatively regulate the activity and stability of the tumor suppressor protein p53—a cellular process initiated by MDM2 and/or MDMX binding to the N-terminal transactivation domain of p53. MDM2 and MDMX in many tumors confer p53 inactivation and tumor survival, and are important molecular targets for anticancer therapy. We screened a duodecimal peptide phage library against site-specifically biotinylated p53-binding domains of human MDM2 and MDMX chemically synthesized via native chemical ligation, and identified several peptide inhibitors of the p53-MDM2/MDMX interactions. The most potent inhibitor (TSFAEYWNLLSP), termed PMI, bound to MDM2 and MDMX at low nanomolar affinities—approximately 2 orders of magnitude stronger than the wild-type p53 peptide of the same length (ETFSDLWKLLPE). We solved the crystal structures of synthetic MDM2 and MDMX, both in complex with PMI, at 1.6 Å resolution. Comparative structural analysis identified an extensive, tightened intramolecular H-bonding network in bound PMI that contributed to its conformational stability, thus enhanced binding to the 2 oncogenic proteins. Importantly, the C-terminal residue Pro of PMI induced formation of a hydrophobic cleft in MDMX previously unseen in the structures of p53-bound MDM2 or MDMX. Our findings deciphered the structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX, shedding new light on structure-based rational design of different classes of p53 activators for potential therapeutic use.
References
51
Referenced
346
10.1038/35042675
10.1038/nrm2147
10.1038/nrc864
10.1200/JCO.1998.16.9.3158
10.1038/nature05529
10.1038/nature05541
10.1016/j.cell.2006.12.007
10.1038/nrc2012
10.1242/jcs.03362
10.1016/S0014-5793(97)01480-4
10.1128/MCB.20.3.1001-1007.2000
10.1002/j.1460-2075.1996.tb00919.x
10.1038/387299a0
10.1038/387296a0
10.1016/j.ccr.2006.03.014
10.1073/pnas.0508476103
10.1128/MCB.23.15.5113-5121.2003
10.1038/sj.emboj.7600145
10.1074/jbc.M213034200
10.1074/jbc.M308295200
10.1002/bip.20741
10.1073/pnas.0708917105
10.1126/science.1092472
10.1158/0008-5472.CAN-07-1140
10.1126/science.274.5289.948
10.1021/ja063102j
10.1021/jm049137g
10.1002/cbic.200500452
- GM Popowicz, et al., Molecular Basis for the Inhibition of p53 by Mdmx. Cell Cycle, pp. 6 (2007). / Cell Cycle / Molecular Basis for the Inhibition of p53 by Mdmx by Popowicz GM (2007)
10.1006/abbi.2000.1998
10.1016/S0022-2836(02)00852-5
10.1006/jmbi.1997.1078
10.1101/gad.8.10.1235
- SM Picksley, B Vojtesek, A Sparks, DP Lane, Immunochemical analysis of the interaction of p53 with MDM2—fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9, 2523–2529 (1994). / Oncogene / Immunochemical analysis of the interaction of p53 with MDM2—fine mapping of the MDM2 binding site on p53 using synthetic peptides by Picksley SM (1994)
10.1002/bip.360221211
- V Bottger, et al., Identification of novel mdm2 binding peptides by phage display. Oncogene 13, 2141–2147 (1996). / Oncogene / Identification of novel mdm2 binding peptides by phage display by Bottger V (1996)
10.1146/annurev.biochem.69.1.923
10.1126/science.7973629
10.1021/ja990935j
10.1021/bi060309g
10.1021/ja804289g
- E Vives, J Schmidt, A Pelegrin, Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 1786, 126–138 (2008). / Biochim Biophys Acta / Cell-penetrating and cell-targeting peptides in drug delivery by Vives E (2008)
10.1021/ja8042036
10.1002/cbic.200500324
10.4161/cc.6365
10.1002/pro.5560041120
10.1107/S0907444903028956
10.1107/S0907444996012255
10.1107/S0907444904019158
10.1016/j.jmb.2008.11.043
10.1074/jbc.M809096200
Dates
Type | When |
---|---|
Created | 16 years, 5 months ago (March 2, 2009, 9:43 p.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 5:35 p.m.) |
Indexed | 2 days, 21 hours ago (Aug. 22, 2025, 12:48 a.m.) |
Issued | 16 years, 5 months ago (March 24, 2009) |
Published | 16 years, 5 months ago (March 24, 2009) |
Published Online | 16 years, 5 months ago (March 24, 2009) |
Published Print | 16 years, 5 months ago (March 24, 2009) |
@article{Pazgier_2009, title={Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX}, volume={106}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0900947106}, DOI={10.1073/pnas.0900947106}, number={12}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Pazgier, Marzena and Liu, Min and Zou, Guozhang and Yuan, Weirong and Li, Changqing and Li, Chong and Li, Jing and Monbo, Juahdi and Zella, Davide and Tarasov, Sergey G. and Lu, Wuyuan}, year={2009}, month=mar, pages={4665–4670} }